Literature DB >> 1614099

[Systemic corticosteroid therapy in non-arteritic anterior ischemic optic neuropathy].

J Menzi1, F Körner.   

Abstract

A non-arteritic anterior ischemic optic neuropathy has usually a poor prognosis. Spontaneous remissions are extremely rare. In contrast to arteritic anterior ischemic neuropathy, systemic corticosteroids are generally accepted to be ineffective. Two cases of bilateral severe non-arteritic anterior ischemic optic neuropathy are reported who underwent full remission of their visual function directly related to high-dose systemic corticosteroids. It is hypothesized that, in acute phases of non-arteritic anterior ischemic optic neuropathy a significant reduction of tissue swelling and consecutive prelaminar reperfusion can be achieved with high-dose corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1614099     DOI: 10.1055/s-2008-1045763

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (NAION): a 3-month, double-masked, randomised, placebo-controlled trial.

Authors:  Barbara Wilhelm; Holger Lüdtke; Helmut Wilhelm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-08       Impact factor: 3.117

2.  Single intravitreal aflibercept injection for unilateral acute nonarteritic ischemic optic neuropathy.

Authors:  Ziya Ayhan; Gamze Kocaoğlu; Aylin Yaman; Meltem Söylev Bajin; A Osman Saatci
Journal:  Case Rep Ophthalmol Med       Date:  2015-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.